Brief: Tandem Diabetes Care Q4 Gross Margin 56%
26/02/2025 21:05
Feb 26 (Reuters) - Tandem Diabetes Care Q4 adjusted operating income USD -30.2 million vs. IBES estimate USD -17.6 million. Q4 operating income USD -600 thousand Q4 net income USD 800 thousand Q4 adjusted net income USD -28.8 million vs. IBES estimate USD -14.9 million outlook FY adjusted EBITDA margin 3%
Recent news on Tandem Diabetes Care
See all newsU.S. STOCKS ON THE MOVE -VF Corp, Biogen, AbbVie
US STOCKS ON THE MOVE-SpaceX, Humana, AbbVie
U.S. STOCKS ON THE MOVE-SpaceX, Humana, Crescent Energy
MedTech growth concerns likely to overshadow Q3 results, Leerink says
Tandem Diabetes Care, Inc. reports results for the quarter ended June 30 - Earnings Summary